logo
Share SHARE
FONT-SIZE Plus   Neg

Optimer Pharma Names Hank McKinnell Chairman - Quick Facts

Optimer Pharmaceuticals (OPTR) announced that its board of directors has appointed Hank McKinnell as its new chairman. The company added that Kurt Hartman, who currently serves as General Counsel, chief compliance officer and senior vice president, has been appointed acting chief financial officer, or CFO, and that a search for a permanent CFO has commenced.

The company noted that the appointments were made after its board of directors removed Dr. Michael Chang as chairman and terminated John Prunty, CFO, and Dr. Youe-Kong Shue, vice president. The Board, excluding Chang, unanimously approved the personnel changes. Chang remains as a director of the company, but the Board has requested his resignation.

According to Optimer Pharma, the changes are not expected to materially impact its revenues or operations, including the commercialization and launch of DIFICID, but were related to certain lapses in corporate governance practices and the company's relationship with Optimer Biotechnology, Inc., its 43%-owned independent, Taiwanese-based affiliate.

Separately, Optimer Pharma stated that based upon preliminary results, it expects to report gross revenues of around $16.45 million for the first quarter of 2012.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT